{"transactions":[{"id":830938,"issuer":{"id":1085,"kind":"organization","name":"AN2 Therapeutics, Inc.","symbol":"ANTX"},"owners":[{"id":56572,"kind":"person","name":"Wong Stephanie","position":1,"cik":"0001555744","reported_name":"Wong Stephanie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-03-23T23:08:16.000Z","date":"2026-03-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":23742,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On March 19, 2026, the board of directors of the Issuer approved the repricing of the option. Except as further described in footnote 1, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":5.91,"expiration_date":"2033-06-06","underlying":"Common Stock","underlying_shares":23742},"source":{"system":"sec-edgar","filing":"0001193125-26-120216","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1880438/000119312526120216/ownership.xml","form_type":"4"}},{"id":830937,"issuer":{"id":1085,"kind":"organization","name":"AN2 Therapeutics, Inc.","symbol":"ANTX"},"owners":[{"id":56572,"kind":"person","name":"Wong Stephanie","position":1,"cik":"0001555744","reported_name":"Wong Stephanie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-03-23T23:08:16.000Z","date":"2026-03-19","kind":"grant","planned":false,"acquired":true,"shares":23742,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price of the option is $3.91 per share, representing the closing price of the Issuer's common stock on the date of the repricing; provided that the exercise price will be increased to the original exercise price before repricing if, prior to the \"Premium End Date\" (as defined below), the repriced option is exercised or the Reporting Person's services with the Company is terminated. The \"Premium End Date\" means the earliest of: (i) September 19, 2027, (ii) the date of a change in control or (iii) the Reporting Person's death or disability."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On March 19, 2026, the board of directors of the Issuer approved the repricing of the option. Except as further described in footnote 1, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested."}],"balance_after":23742,"derivative":{"exercise_price":3.91,"expiration_date":"2033-06-06","underlying":"Common Stock","underlying_shares":23742},"source":{"system":"sec-edgar","filing":"0001193125-26-120216","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1880438/000119312526120216/ownership.xml","form_type":"4"}},{"id":830936,"issuer":{"id":1085,"kind":"organization","name":"AN2 Therapeutics, Inc.","symbol":"ANTX"},"owners":[{"id":56572,"kind":"person","name":"Wong Stephanie","position":1,"cik":"0001555744","reported_name":"Wong Stephanie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-03-23T23:08:16.000Z","date":"2026-03-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":10362,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On March 19, 2026, the board of directors of the Issuer approved the repricing of the option. Except as further described in footnote 1, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":17.28,"expiration_date":"2032-05-11","underlying":"Common Stock","underlying_shares":10362},"source":{"system":"sec-edgar","filing":"0001193125-26-120216","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1880438/000119312526120216/ownership.xml","form_type":"4"}},{"id":830935,"issuer":{"id":1085,"kind":"organization","name":"AN2 Therapeutics, Inc.","symbol":"ANTX"},"owners":[{"id":56572,"kind":"person","name":"Wong Stephanie","position":1,"cik":"0001555744","reported_name":"Wong Stephanie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-03-23T23:08:16.000Z","date":"2026-03-19","kind":"grant","planned":false,"acquired":true,"shares":10362,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price of the option is $3.91 per share, representing the closing price of the Issuer's common stock on the date of the repricing; provided that the exercise price will be increased to the original exercise price before repricing if, prior to the \"Premium End Date\" (as defined below), the repriced option is exercised or the Reporting Person's services with the Company is terminated. The \"Premium End Date\" means the earliest of: (i) September 19, 2027, (ii) the date of a change in control or (iii) the Reporting Person's death or disability."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On March 19, 2026, the board of directors of the Issuer approved the repricing of the option. Except as further described in footnote 1, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested."}],"balance_after":10362,"derivative":{"exercise_price":3.91,"expiration_date":"2032-05-11","underlying":"Common Stock","underlying_shares":10362},"source":{"system":"sec-edgar","filing":"0001193125-26-120216","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1880438/000119312526120216/ownership.xml","form_type":"4"}},{"id":830934,"issuer":{"id":1085,"kind":"organization","name":"AN2 Therapeutics, Inc.","symbol":"ANTX"},"owners":[{"id":56572,"kind":"person","name":"Wong Stephanie","position":1,"cik":"0001555744","reported_name":"Wong Stephanie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-03-23T23:08:16.000Z","date":"2026-03-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":24999,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On March 19, 2026, the board of directors of the Issuer approved the repricing of the option. Except as further described in footnote 1, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":6.596,"expiration_date":"2031-04-29","underlying":"Common Stock","underlying_shares":24999},"source":{"system":"sec-edgar","filing":"0001193125-26-120216","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1880438/000119312526120216/ownership.xml","form_type":"4"}},{"id":830933,"issuer":{"id":1085,"kind":"organization","name":"AN2 Therapeutics, Inc.","symbol":"ANTX"},"owners":[{"id":56572,"kind":"person","name":"Wong Stephanie","position":1,"cik":"0001555744","reported_name":"Wong Stephanie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-03-23T23:08:16.000Z","date":"2026-03-19","kind":"grant","planned":false,"acquired":true,"shares":24999,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price of the option is $3.91 per share, representing the closing price of the Issuer's common stock on the date of the repricing; provided that the exercise price will be increased to the original exercise price before repricing if, prior to the \"Premium End Date\" (as defined below), the repriced option is exercised or the Reporting Person's services with the Company is terminated. The \"Premium End Date\" means the earliest of: (i) September 19, 2027, (ii) the date of a change in control or (iii) the Reporting Person's death or disability."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On March 19, 2026, the board of directors of the Issuer approved the repricing of the option. Except as further described in footnote 1, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested."}],"balance_after":24999,"derivative":{"exercise_price":3.91,"expiration_date":"2031-04-29","underlying":"Common Stock","underlying_shares":24999},"source":{"system":"sec-edgar","filing":"0001193125-26-120216","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1880438/000119312526120216/ownership.xml","form_type":"4"}},{"id":888257,"issuer":{"id":1085,"kind":"organization","name":"AN2 Therapeutics, Inc.","symbol":"ANTX"},"owners":[{"id":56572,"kind":"person","name":"Wong Stephanie","position":1,"cik":"0001555744","reported_name":"Wong Stephanie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-23T21:28:06.000Z","date":"2026-02-20","kind":"grant","planned":false,"acquired":true,"shares":20400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares shall vest on February 20, 2027, subject to the Reporting Person providing continuous service through such date."}],"balance_after":20400,"derivative":{"exercise_price":1.04,"expiration_date":"2036-02-19","underlying":"Common Stock","underlying_shares":20400},"source":{"system":"sec-edgar","filing":"0001193125-26-064089","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1880438/000119312526064089/ownership.xml","form_type":"4"}},{"id":1135578,"issuer":{"id":1085,"kind":"organization","name":"AN2 Therapeutics, Inc.","symbol":"ANTX"},"owners":[{"id":56572,"kind":"person","name":"Wong Stephanie","position":1,"cik":"0001555744","reported_name":"Wong Stephanie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-23T20:56:15.000Z","date":"2025-05-22","kind":"grant","planned":false,"acquired":true,"shares":19111,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares shall vest on March 31, 2026, subject to the Reporting Person providing continuous service through such date."}],"balance_after":19111,"derivative":{"exercise_price":1.19,"expiration_date":"2035-05-21","underlying":"Common Stock","underlying_shares":19111},"source":{"system":"sec-edgar","filing":"0000950170-25-077053","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1880438/000095017025077053/ownership.xml","form_type":"4"}},{"id":1472244,"issuer":{"id":1085,"kind":"organization","name":"AN2 Therapeutics, Inc.","symbol":"ANTX"},"owners":[{"id":56572,"kind":"person","name":"Wong Stephanie","position":1,"cik":"0001555744","reported_name":"Wong Stephanie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-21T21:50:49.000Z","date":"2024-06-19","kind":"grant","planned":false,"acquired":true,"shares":64503,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares shall vest on the earlier of (a) the one-year anniversary of June 19, 2024 or (b) the day prior to the date of the Issuer's next annual stockholder meeting, subject to the Reporting Person providing continuous service through such vesting date."}],"balance_after":64503,"derivative":{"exercise_price":2,"expiration_date":"2034-06-18","underlying":"Common Stock","underlying_shares":64503},"source":{"system":"sec-edgar","filing":"0000950170-24-076361","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1880438/000095017024076361/ownership.xml","form_type":"4"}},{"id":1860917,"issuer":{"id":1085,"kind":"organization","name":"AN2 Therapeutics, Inc.","symbol":"ANTX"},"owners":[{"id":56572,"kind":"person","name":"Wong Stephanie","position":1,"cik":"0001555744","reported_name":"Wong Stephanie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option\n(right to buy)","published_at":"2023-06-10T00:49:59.000Z","date":"2023-06-07","kind":"grant","planned":false,"acquired":true,"shares":23742,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares shall vest on the earlier of (a) the one-year anniversary of June 7, 2023 or (b) the day prior to the date of the Issuer's next annual stockholder meeting, subject to the Reporting Person providing continuous service through such vesting date."}],"balance_after":23742,"derivative":{"exercise_price":5.91,"expiration_date":"2033-06-06","underlying":"Common Stock","underlying_shares":23742},"source":{"system":"sec-edgar","filing":"0000899243-23-015317","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1880438/000089924323015317/doc4.xml","form_type":"4"}},{"id":2046369,"issuer":{"id":113073,"kind":"organization","name":"Calithera Biosciences, Inc.","symbol":"CALA"},"owners":[{"id":56572,"kind":"person","name":"Wong Stephanie","position":1,"cik":"0001555744","reported_name":"Wong Stephanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-01-25T16:00:16.000Z","date":"2023-01-23","kind":"tax_withholding","acquired":false,"shares":317,"price":0.4461,"value":141.4137,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on January 23, 2023 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees."}],"balance_after":6287,"source":{"system":"sec-edgar","filing":"0000899243-23-002609","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496671/000089924323002609/doc4.xml","form_type":"4"}},{"id":2270604,"issuer":{"id":1085,"kind":"organization","name":"AN2 Therapeutics, Inc.","symbol":"ANTX"},"owners":[{"id":56572,"kind":"person","name":"Wong Stephanie","position":1,"cik":"0001555744","reported_name":"Wong Stephanie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-05-17T01:22:13.000Z","date":"2022-05-12","kind":"grant","acquired":true,"shares":10362,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest as follows: 1/12 of the shares shall vest on each monthly anniversary as measured from March 25, 2022."}],"balance_after":10362,"derivative":{"exercise_price":17.28,"expiration_date":"2032-05-11","underlying":"Common Stock","underlying_shares":10362},"source":{"system":"sec-edgar","filing":"0000899243-22-018289","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1880438/000089924322018289/doc4.xml","form_type":"4"}},{"id":2424003,"issuer":{"id":113073,"kind":"organization","name":"Calithera Biosciences, Inc.","symbol":"CALA"},"owners":[{"id":56572,"kind":"person","name":"Wong Stephanie","position":1,"cik":"0001555744","reported_name":"Wong Stephanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-01-27T16:17:40.000Z","date":"2022-01-25","kind":"grant","acquired":true,"shares":215000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth (1/4th) of the Option vests one year after January 25, 2022; the balance of the Option vests in a series of thirty-six (36) successive equal monthly installments thereafter. The Option shall be subject to accelerated vesting as set forth in the optionee's employment agreement with the Company."}],"balance_after":215000,"derivative":{"exercise_price":0.44,"expiration_date":"2032-01-24","underlying":"Common Stock","underlying_shares":215000},"source":{"system":"sec-edgar","filing":"0000899243-22-003440","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496671/000089924322003440/doc4.xml","form_type":"4"}},{"id":2426639,"issuer":{"id":113073,"kind":"organization","name":"Calithera Biosciences, Inc.","symbol":"CALA"},"owners":[{"id":56572,"kind":"person","name":"Wong Stephanie","position":1,"cik":"0001555744","reported_name":"Wong Stephanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-01-25T16:05:37.000Z","date":"2022-01-21","kind":"tax_withholding","acquired":false,"shares":5586,"price":0.4915,"value":2745.519,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on January 21, 2022 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees."}],"balance_after":132085,"source":{"system":"sec-edgar","filing":"0000899243-22-003138","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496671/000089924322003138/doc4.xml","form_type":"4"}},{"id":2441499,"issuer":{"id":113073,"kind":"organization","name":"Calithera Biosciences, Inc.","symbol":"CALA"},"owners":[{"id":56572,"kind":"person","name":"Wong Stephanie","position":1,"cik":"0001555744","reported_name":"Wong Stephanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-01-06T21:00:10.000Z","date":"2022-01-04","kind":"tax_withholding","acquired":false,"shares":18077,"price":0.6604,"value":11938.0508,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on January 4, 2022 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees."}],"balance_after":137671,"source":{"system":"sec-edgar","filing":"0000899243-22-001298","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496671/000089924322001298/doc4.xml","form_type":"4"}},{"id":2519587,"issuer":{"id":113073,"kind":"organization","name":"Calithera Biosciences, Inc.","symbol":"CALA"},"owners":[{"id":56572,"kind":"person","name":"Wong Stephanie","position":1,"cik":"0001555744","reported_name":"Wong Stephanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-11-09T19:34:28.000Z","date":"2021-11-08","kind":"tax_withholding","acquired":false,"shares":15566,"price":0.87,"value":13542.42,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on November 8, 2021 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees."}],"balance_after":155748,"source":{"system":"sec-edgar","filing":"0000899243-21-043687","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1496671/000089924321043687/doc4.xml","form_type":"4"}},{"id":2519586,"issuer":{"id":113073,"kind":"organization","name":"Calithera Biosciences, Inc.","symbol":"CALA"},"owners":[{"id":56572,"kind":"person","name":"Wong Stephanie","position":1,"cik":"0001555744","reported_name":"Wong Stephanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-11-09T19:34:28.000Z","date":"2021-11-05","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of Common Stock were acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person."}],"balance_after":171314,"source":{"system":"sec-edgar","filing":"0000899243-21-043687","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496671/000089924321043687/doc4.xml","form_type":"4"}},{"id":2531895,"issuer":{"id":113073,"kind":"organization","name":"Calithera Biosciences, Inc.","symbol":"CALA"},"owners":[{"id":56572,"kind":"person","name":"Wong Stephanie","position":1,"cik":"0001555744","reported_name":"Wong Stephanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-10-29T18:50:29.000Z","date":"2021-10-28","kind":"tax_withholding","acquired":false,"shares":45965,"price":1.89,"value":86873.85,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on October 28, 2021 and October 29, 2021 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees."}],"balance_after":141314,"source":{"system":"sec-edgar","filing":"0000899243-21-042068","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1496671/000089924321042068/doc4.xml","form_type":"4"}},{"id":2531894,"issuer":{"id":113073,"kind":"organization","name":"Calithera Biosciences, Inc.","symbol":"CALA"},"owners":[{"id":56572,"kind":"person","name":"Wong Stephanie","position":1,"cik":"0001555744","reported_name":"Wong Stephanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-10-29T18:50:29.000Z","date":"2021-10-27","kind":"grant","acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of Common Stock were acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person."}],"balance_after":187279,"source":{"system":"sec-edgar","filing":"0000899243-21-042068","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496671/000089924321042068/doc4.xml","form_type":"4"}},{"id":2899243,"issuer":{"id":113073,"kind":"organization","name":"Calithera Biosciences, Inc.","symbol":"CALA"},"owners":[{"id":56572,"kind":"person","name":"Wong Stephanie","position":1,"cik":"0001555744","reported_name":"Wong Stephanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-01-22T20:13:39.000Z","date":"2021-01-20","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One-fourth (1/4th) of the Option vests one year after January 20, 2021; the balance of the Option vests in a series of thirty-six (36) successive equal monthly installments thereafter.  The Option shall be subject to accelerated vesting as set forth in the optionee's employment agreement with the Company."}],"balance_after":150000,"derivative":{"exercise_price":2.98,"expiration_date":"2031-01-20","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0000899243-21-003037","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1496671/000089924321003037/doc4.xml","form_type":"4"}},{"id":2899242,"issuer":{"id":113073,"kind":"organization","name":"Calithera Biosciences, Inc.","symbol":"CALA"},"owners":[{"id":56572,"kind":"person","name":"Wong Stephanie","position":1,"cik":"0001555744","reported_name":"Wong Stephanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-01-22T20:13:39.000Z","date":"2021-01-20","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The shares of Common Stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall fully vest on January 3, 2022.  The Restricted Stock Unit shall be subject to accelerated vesting as set forth in the optionee's employment agreement with the Company."}],"balance_after":103156,"source":{"system":"sec-edgar","filing":"0000899243-21-003037","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1496671/000089924321003037/doc4.xml","form_type":"4"}},{"id":2899241,"issuer":{"id":113073,"kind":"organization","name":"Calithera Biosciences, Inc.","symbol":"CALA"},"owners":[{"id":56572,"kind":"person","name":"Wong Stephanie","position":1,"cik":"0001555744","reported_name":"Wong Stephanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-01-22T20:13:39.000Z","date":"2021-01-20","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of Common Stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall vest as follows: one-fourth (1/4th) of the shares subject to the Restricted Stock Unit will vest each year after January 20, 2021 until the Restricted Stock Units are fully vested.  The Restricted Stock Unit shall be subject to accelerated vesting as set forth in the optionee's employment agreement with the Company."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 855 shares acquired June 10, 2020, and 1,342 shares acquired December 10, 2020 under the Company's 2014 Employee Stock Purchase Plan."}],"balance_after":73156,"source":{"system":"sec-edgar","filing":"0000899243-21-003037","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496671/000089924321003037/doc4.xml","form_type":"4"}},{"id":3174077,"issuer":{"id":113073,"kind":"organization","name":"Calithera Biosciences, Inc.","symbol":"CALA"},"owners":[{"id":56572,"kind":"person","name":"Wong Stephanie","position":1,"cik":"0001555744","reported_name":"Wong Stephanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR. VP, FINANCE & SECRETARY"}}],"security":"Common Stock","published_at":"2020-04-17T16:05:34.000Z","date":"2020-04-15","kind":"sale","acquired":false,"shares":5000,"price":8,"value":40000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to a Rule 10b5-1 Trading Plan."}],"balance_after":30082,"source":{"system":"sec-edgar","filing":"0000899243-20-010902","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496671/000089924320010902/doc4.xml","form_type":"4"}},{"id":3305273,"issuer":{"id":113073,"kind":"organization","name":"Calithera Biosciences, Inc.","symbol":"CALA"},"owners":[{"id":56572,"kind":"person","name":"Wong Stephanie","position":1,"cik":"0001555744","reported_name":"Wong Stephanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR. VP, FINANCE & SECRETARY"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-01-22T18:12:57.000Z","date":"2020-01-17","kind":"grant","acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth (1/4th) of the Option vests one year after January 17, 2020; the balance of the Option vests in a series of thirty-six (36) successive equal monthly installments thereafter. The Option shall be subject to accelerated vesting as set forth in the optionee's employment agreement with the Company."}],"balance_after":120000,"derivative":{"exercise_price":7.41,"expiration_date":"2030-01-17","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0000899243-20-001694","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496671/000089924320001694/doc4.xml","form_type":"4"}},{"id":3481411,"issuer":{"id":113073,"kind":"organization","name":"Calithera Biosciences, Inc.","symbol":"CALA"},"owners":[{"id":56572,"kind":"person","name":"Wong Stephanie","position":1,"cik":"0001555744","reported_name":"Wong Stephanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR. VP, FINANCE & SECRETARY"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-06-21T16:05:26.000Z","date":"2019-06-19","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-forty-eighth (1/48th) of the Option vests in equal monthly installments one month after April 1, 2014. The Option shall be subject to accelerated vesting as set forth in the optionee's employment agreement with the Company."}],"balance_after":13284,"derivative":{"exercise_price":2.64,"expiration_date":"2024-04-14","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-19-017790","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1496671/000089924319017790/doc4.xml","form_type":"4"}},{"id":3481410,"issuer":{"id":113073,"kind":"organization","name":"Calithera Biosciences, Inc.","symbol":"CALA"},"owners":[{"id":56572,"kind":"person","name":"Wong Stephanie","position":1,"cik":"0001555744","reported_name":"Wong Stephanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR. VP, FINANCE & SECRETARY"}}],"security":"Common Stock","published_at":"2019-06-21T16:05:26.000Z","date":"2019-06-19","kind":"exercise","acquired":true,"shares":10000,"price":2.64,"value":26400.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 2,500, 2,500 and 1,751 shares acquired under the Company's 2014 Employee Stock Purchase Plan on June 8, 2018, December 10, 2018 and June 10, 2019, respectively."}],"balance_after":31751,"source":{"system":"sec-edgar","filing":"0000899243-19-017790","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496671/000089924319017790/doc4.xml","form_type":"4"}},{"id":3696427,"issuer":{"id":113073,"kind":"organization","name":"Calithera Biosciences, Inc.","symbol":"CALA"},"owners":[{"id":56572,"kind":"person","name":"Wong Stephanie","position":1,"cik":"0001555744","reported_name":"Wong Stephanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR. VP, FINANCE & SECRETARY"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-01-14T16:30:49.000Z","date":"2019-01-10","kind":"grant","acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth (1/4th) of the Option vests one year after January 10, 2019; the balance of the Option vests in a series of thirty-six (36) successive equal monthly installments thereafter.  The Option shall be subject to accelerated vesting as set forth in the optionee's employment agreement with the Company."}],"balance_after":120000,"derivative":{"exercise_price":4.64,"expiration_date":"2029-01-09","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0000899243-19-001126","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496671/000089924319001126/doc4.xml","form_type":"4"}},{"id":4030336,"issuer":{"id":113073,"kind":"organization","name":"Calithera Biosciences, Inc.","symbol":"CALA"},"owners":[{"id":56572,"kind":"person","name":"Wong Stephanie","position":1,"cik":"0001555744","reported_name":"Wong Stephanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR VP, FINANCE AND SECRETARY"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-02-27T19:26:53.000Z","date":"2018-02-23","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-forty-eighth (1/48th) of the Option vests in equal monthly installments one month after April 1, 2014. The Option shall be subject to accelerated vesting as set forth in the optionee's employment agreement with the Company."}],"balance_after":21596,"derivative":{"exercise_price":2.64,"expiration_date":"2024-04-14","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-18-005710","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1496671/000089924318005710/doc4.xml","form_type":"4"}},{"id":4030335,"issuer":{"id":113073,"kind":"organization","name":"Calithera Biosciences, Inc.","symbol":"CALA"},"owners":[{"id":56572,"kind":"person","name":"Wong Stephanie","position":1,"cik":"0001555744","reported_name":"Wong Stephanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR VP, FINANCE AND SECRETARY"}}],"security":"Common Stock","published_at":"2018-02-27T19:26:53.000Z","date":"2018-02-23","kind":"exercise","acquired":true,"shares":10000,"price":2.64,"value":26400.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 2,500 shares acquired under the Company's 2014 Employee Stock Purchase Plan on December 8, 2017."}],"balance_after":15000,"source":{"system":"sec-edgar","filing":"0000899243-18-005710","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496671/000089924318005710/doc4.xml","form_type":"4"}},{"id":4099357,"issuer":{"id":113073,"kind":"organization","name":"Calithera Biosciences, Inc.","symbol":"CALA"},"owners":[{"id":56572,"kind":"person","name":"Wong Stephanie","position":1,"cik":"0001555744","reported_name":"Wong Stephanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR. VP, FINANCE & SECRETARY"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-01-16T16:07:08.000Z","date":"2018-01-11","kind":"grant","acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth (1/4th) of the Option vests one year after January 11, 2018; the balance of the Option vests in a series of thirty-six (36) successive equal monthly installments thereafter.  The Option shall be subject to accelerated vesting as set forth in the optionee's employment agreement with the Company."}],"balance_after":70000,"derivative":{"exercise_price":8.6,"expiration_date":"2028-01-10","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0000899243-18-001075","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496671/000089924318001075/doc4.xml","form_type":"4"}},{"id":4254521,"issuer":{"id":113073,"kind":"organization","name":"Calithera Biosciences, Inc.","symbol":"CALA"},"owners":[{"id":56572,"kind":"person","name":"Wong Stephanie","position":1,"cik":"0001555744","reported_name":"Wong Stephanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, FINANCE AND SECRETARY"}}],"security":"Common Stock","published_at":"2017-07-19T16:06:38.000Z","date":"2017-07-17","kind":"sale","acquired":false,"shares":3552,"price":18.4078,"value":65384.5056,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to a Rule10b5-1 Trading Plan adopted on June 16, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $17.90 to $18.65, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares were held by the Wong Family Trust, of which the reporting person is a trustee."}],"balance_after":10550,"source":{"system":"sec-edgar","filing":"0000899243-17-018552","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496671/000089924317018552/doc4.xml","form_type":"4"}}]}